XOANACYL is an oral therapy designed to address critical challenges in CKD, including Iron deficiency and hyperphosphatemia Averoa submitted XOANACYL…
New bench top ²¹²Pb generator to expand clinical-grade isotope supply for targeted alpha therapy research and development June 12, 2025…
RIYADH, Saudi Arabia, June 11, 2025 (GLOBE NEWSWIRE) -- In a landmark medical achievement, King Faisal Specialist Hospital & Research…
Automated screening cuts patient assessment time by 30 minutes in real-world useBOSTON--(BUSINESS WIRE)--Wysa, the global leader in AI-guided mental health…
CONCORD, Calif.--(BUSINESS WIRE)--Raintree Systems, a leading provider of native-built AI-powered electronic health records (EHR), patient engagement, and revenue cycle management…
VERO BEACH, June 10, 2025 (GLOBE NEWSWIRE) -- PeterMD, a Florida-based men's health telemedicine provider, has updated its official website…
New global education initiative unveiled at 2025 PTCOG Annual Conference Louvain-la-Neuve, Belgium, 4 June 2025 - IBA (Ion Beam Applications…
46% reduction in the risk of disease progression or death, and 27% reduction in the risk of death, in an…
Ad hoc announcement pursuant to Art. 53 LR At interim analysis, PSMAddition trial met its primary endpoint showing statistically significant…
Extended Phase 1b trial follow-up on IMA203 PRAME cell therapy in 33 heavily pretreated patients with metastatic melanoma demonstrates favorable…